Maintaining excellent outcomes: the impact of age cutoff reclassification on reduced therapy for neuroblastoma patients

Other authors

Institut Català de la Salut

Grup de Recerca de Càncer i Malalties Hematològiques Infantils, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-01-15T08:45:48Z

2024-01-15T08:45:48Z

2023-11-28



Abstract

Survival; Neuroblastoma; Risk stratification


Supervivència; Neuroblastoma; Estratificació del risc


Supervivencia; Neuroblastoma; Estratificación del riesgo


This work was funded by Instituto de Salud Carlos III through the projects “PI20/000530”, “ICI21000/76” (Co-funded by the European Regional Development Fund/European Social Fund; “A way to make Europe”/“Investing in your future”).

Document Type

Article


Published version

Language

English

Publisher

AME Publishing Company

Related items

Translational Pediatrics;12(11)

https://doi.org/10.21037/tp-23-391

info:eu-repo/grantAgreement/ES/PE2017-2020/PI20%2F000530

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial-NoDerivatives 4.0 International

http://creativecommons.org/licenses/by-nc-nd/4.0/

This item appears in the following Collection(s)